ANRV386-GG10-23ARI29July200915:38
Knowledgeofgeneticanatomyishavingacom-
parablystrongandpervasiveinﬂuenceonallof

medicine....Genomicanatomypermitsmedicine
tobecomemorepredictiveandpreventive.Atthe

sametime,diagnosisandtreatmentarerendered

moresensitive,speciﬁc,effective,andsafe.
–VictorA.McKusick,2001(50)
Benotconformedtothisworld,butbeyetrans-
formedbytherenewingofyourmind.
Romans12:2
INTRODUCTIONTheOldOrderAmishandOldOrder
Mennonite(Plain)peopleofNorthAmerica

havecontributedmuchtoourunderstanding

ofhumangenetics.Althoughwaryoftechnol-

ogy,theyhavecooperatedwithclinicalinves-

tigatorsformorethan40years,believingthe

knowledgegainedcouldhelpalleviatesuffer-

ingintheirowncommunitiesandelsewhere.

ThehistoryofgeneticdiscoveryamongPlain

sectshasbroadrelevance:Itchartsthetrans-

formationofhumangeneticsfromanesoteric

disciplineintoafoundationofclinicalmedicine

(50).Beginningin1962,inheriteddisorders
amongOldOrdercommunitieswerethesub-

jectofexceptionalobservationalstudies,col-

lectedinthe1978landmark
MedicalGenetic
StudiesintheAmish
(1).Between1975and1988,
theadventofSouthernblotting(80),genetic

markers(17),linkageanalysis,DNAsequenc-

ing(48,76),andthepolymerasechainreaction

(PCR)(12)enabledinvestigatorstodescribe

thesedisordersinmoreprecisemolecularterms

(31,43,66,71,74,75,81).Recently,single-

nucleotidepolymorphism(SNP)microarray

technologyhasacceleratedthisprocess(67,68,

89,90)andprovidedfascinatingdetailsabout

thegeneticstructureofinbredpopulations.
Overthepasttwodecades,thefocushas
shiftedtotreatment.Geneticstudieswithin

OldOrderpopulationshaverevealedhowper-

sonalgeneticinformationcanbeintegratedinto
everydayclinicalpractice(23,37,50).Here,we
presentoriginalaswellaspreviouslypublished

datathatinformthelargerﬁeldofgenomicsand

fulﬁllacentralpromiseoftheHumanGenome

Project—toharnessgeneticknowledgetoheal

thesick(88),preventdisability(87),andreduce

medicalcosts(59,87–89).
THEPLAINPOPULATIONS
ContemporaryOldOrdergroupsfallunderthe

collectivetermPlainpeople,whichrefersto

Christiangroupsthatlivesimply,dressplainly,

andliveinthemodernworldbutremainsep-

aratefromit.TheyincludetheAmish,Old

OrderandConservativeMennonites,Old

OrderBrethren,andHutterites(D.Kraybill,

personalcommunication).Ourclinicalpractice

servesOldOrderAmishandMennonitepeo-

pleofPennsylvaniaandMaryland,whoarethe

focusofthisreview.
TheAnabaptistmovementbeganin1525
amidtheProtestantReformation.Itwasbased

ontheideathatbaptismshouldbeaninten-

tionalactofadultswhowantedtojoinan

austereChristiancommunity(41,65,69).For

thisandotherbeliefs,earlyAnabaptistswere

torturedandkilledashereticsformorethan

200yearsastheymovedthroughoutEurope

inexile.Bythe1670s,mosthadsettledin

Switzerland(65).JakobAmman(1656–1730),a

MennonitebishoplivinginthecantonofBerne,

believedthatmanyAnabaptistshadcompro-

misedtheirreligiousdisciplinetoavoidper-

secution(41).Heinsisteduponthepractice

ofshunning(
Meidung),thesocialexclusionof
noncompliantchurchmembers,andin1693

forcedadivisionamongMennonitepreachers

thatmarkedtheformationoftheAmishchurch

(41).WilliamPennofferedAnabaptistsasylum
intheNewWorld,andseveralthousandar-

rivedintheportofPhiladelphiabetween1683

and1770.TheMennonitesgenerallyappeared

earlierintherecords,whereastheAmishar-

rivedinthelatterhalfofthismigration(1727–

1770).SeveralhundredAmishandMennonites
514Strauss
·Puffenberger
 ANRV386-GG10-23ARI29July200915:38
eventuallysettledinLancasterCounty(27,65,
69).Thepresent-dayLancasterCountyAmish

populationofapproximately50,000individu-

alsisderivedfromperhaps50to200ofthese

originalfounders(54).MostearlyAnabaptist

settlementsinPennsylvaniafailed,andresid-

ualmembersjoinedlaterAnabaptistimmi-

grantswhomovedwesttoOhio,Indiana,and

Illinois(54),wheretheyremainconcentrated.

About70%ofcontemporaryAmishoccupyjust

fourcounties:LancasterCounty,Pennylvania;

HolmesandGeaugaCounties,Ohio;and

LaGrangeCounty,Indiana(54).TheOld

OrderAmishinAmericahavedoubledinthe

last16yearstoapproximately226,395individ-

uals(D.Kraybill,personalcommunication).
FollowingthemigrationtoNorthAmerica,
AmishculturebecameextinctinEurope(41),

whileforcesofassimilationandchangereached

Anabaptistimmigrants.SomeregionalAmish

andMennonitechurcheswerefurtherdivided

byideologicalconﬂicts(65),andbythe1860s

groupsthatheldfasttotraditionweredes-

ignatedtheOldOrderbytheirmorepro-

gressivecounterparts(41,65).Philosophical

differences,reinforcedbygeographicalsepara-

tionresultedinmanyendogamoussubdivisions

calleddemes.
MEDICALGENETICSTUDIES
In1962,Dr.VictorA.McKusickreviewedJohn

Hostetler’s
AmishSociety
forJohnsHopkins
UniversityPressandrecognizedthepotential

forusingtheAmishtostudymedicalgenetics

(Table1
)(54).Thatsameyear,hereadabout
DavidKrusen,aLancasterCountydoctorwho

reportedahighprevalenceofachondroplasia

amongtheAmish.Theseeventssparkeda

productivecollaborationbetweenMcKusick

andHostetler(54),andMcKusickmadehis

ﬁrstﬁeldtripstoLancasterCountywithDr.

Krusen(31).Hesoonrecognizedthatdwarﬁsm

amongtheAmishwasnotachondroplasia,

butrathertwodistinctrecessiveconditions:

Ellis-vanCreveldsyndromeandcartilage-hair

hypoplasia(
Figure1
)(52,53).
Figure1
ThisAmishboywithcartilage-hairhypoplasiahas
thecharacteristicphysicalfeaturesofshort-limbed

dwarﬁsm,sparsehair,andsmallnails.Hesuffered

fromneuronalintestinaldysplasiaandcombined

immunedeﬁciency,rarecomplicationsofthe

disorder,andhadabonemarrowtransplantat

28monthsofage.Hediedofintractable

autoimmunehemolyticanemiaoneyearlater

(photousedwithparentpermission).
Overthenext16years,theAmishwere
subjectsofdiversegeneticstudies.Manyof

theseweredetailedclinicaldescriptionsofre-

cessivedisorders,buttherewerealsostudies

aboutbloodgroups(16),HLAantigens(42),

immunoglobulinlevels(56),chromosomalvari-

ation(35),andtheheritabilityofcomplextraits

(e.g.,bloodpressure,glucosetolerance,and

cancerrisk)(26,44,72).Seminalworksfrom

thiseraarecollectedinthe1978publication

MedicalGeneticStudiesintheAmish
(1),editedby
McKusick,whichdescribes18previouslyrec-

ognizedand16newlydiagnosedMendeliandis-

ordersamongtheAmishofPennsylvania,Ohio,

andMidwesternstates.
MedicalGeneticStudies
intheAmish
establishedmanyknownprinciples
ofpopulationgeneticsthatremainpertinent

today(
Table1
).www.annualreviews.org
•Genetics,Medicine,andthePlainPeople515
 ANRV386-GG10-23ARI29July200915:38
Table1CharacteristicsofPlainpopulationsconducivetogeneticstudies
McKusicketal.1964(53)
•Aself-deﬁned,closedpopulation(littlegeneinﬂow)
•WesternEuropeanorigin
•Smallnumberoffoundingmembers
•Concentratedpopulationsettlements(relativeimmobility)
•Extensivegeneologicalrecords
•Highstandardsofliving(i.e.,nutrition,hygiene)andphysicalhealth
•Stronginterestininheritedillnessandthehealingarts
•Relativelyuniformsocial,economic,andoccupationalcircumstances
•Largesibships(e.g.,average5–8perfamily)
•Lowillegitimacyrate
•Childrenwithbirthdefectsorgeneticdisorderscaredforathome
•Multiplediscretesubpopulations(demes)allowcomparativeanalysis
Molecularupdate,2008

•Largehaplotypeblocks(smallpopulationofrecentorigin)fromidentity-by-descentarounddiseaseloci
•Mutationhomogeneity(foundereffect)
•Population-speciﬁcallelefrequencies
Beforetheadventofmoleculargenetictech-
nology,McKusickusedgenealogicalrecords

toinferidentity-by-descentforpathogenic

alleles.Hetracedthemutationforpyruvate

kinasedeﬁciencyto“StrongJacob”Yoder

andhiswife,whoimmigratedin1742,and

tracedtheEllis-vanCreveldallelethrough

40sibships,73affectedindividuals,and80

parentstoSamuelKingandhiswife,who

alsoimmigratedinthe1740s(49).Although

complexpedigreeanalysisisseldomnecessary

today,thesestudieshighlightedtheadvantages

ofgeneticlinkageanalysisanddiseasegene

mappinginPlainpopulations.
MOLECULARGENETICSTUDIES
PopulationGenetics
Earlyinvestigatorsrecognizedthedistinctna-
tureofAmishdemesbasedontheirimmi-

grationhistoryandsurnamedistribution(49).

Surnamesareinheritedthroughthepater-

nalline,largelyindependentofselection

orinbreeding.Deviationsintheirfrequency

withinapopulationovertimesimulateran-

domgeneticdrift.Presently,thenameStoltzfus

accountsfor26%ofAmishhouseholdsin

LancasterCounty.Threeothersurnames
(King,Fisher,andBeiler)eachaccountfor
10%–12%ofthetotal.Similarly,among

WeaverlandandGroffdaleMennonites,the

surnameMartinaccountsfor20%ofhouse-

holds.MitochondrialDNAhaplotypes,inher-

itedthroughthematernalline,demonstrate

similardriftoverthelast12–14generations

(Table2
).WithineachAnabaptistsubpopula-
tion,pathogenicallelesmayalsoincrease(orde-

crease)infrequencybyrandomchance.When

thefoundingpopulationissmall,randomallele

frequencyshiftsfromonegenerationtothenext

canbeprofound;someraremutationsbecome

quitecommon,whileothersbecomeextinct.
Thisunderlyinggeneticstructuremade
Plainpopulationsidealforearlygeneticmap-

pingstudies,whichreliedonlargecollectionsof

patientsandtraditionallinkageanalysis.Formal

linkageanalysiswasnecessarybecauseDNA

markersweresparseandgenotypingwastime-

consumingandexpensive.Typically,300–400

microsatellitemarkersweregenotypedinaf-

fectedindividuals,theirparents,andsiblingsin

anattempttolinkaphenotypetoagenomic

region.ManymappingstudiesinPlainpopula-

tionshaveidentiﬁeddiseasegenesinthisway

(6,13,19,20,47,62,63,66,74,75,81,92,95).
Ithaslongbeenknownthatisolatedpop-
ulationshaveahighincidenceofraregenetic
516Strauss
·Puffenberger
 ANRV386-GG10-23ARI29July200915:38
Table2Afrequencydistributionofsurnamesandmitochondrialhypervariableregion(HVR1)haplotypesamongfour
PennsylvaniaAmishandMennonitedemes
1Groffdale
Weaverland
LancasterJuniataandMifßin
MennonitesMennonitesAmishAmishSurnameMartin18%21%0%0%Zimmerman18%9%0%0%Hoover8%6%0%0%Nolt7%5%0%0%Weaver
5%7%0%0%Stoltzfus/Stoltzfoos0%0%26%0%King0%0%12%0%Fisher0%0%11%0%Beiler/Byler0%0%11%7%Peachey0%0%0%29%Swarey0%0%0%13%Kanagy0%0%0%11%Yoder
0%0%1%11%mtDNAhaplotype
16298C16311C20%5%0%0%1669T16126C16261T13%19%0%0%Cambridgereference
8%0%0%38%16304C7%5%0%8%1693C16304C6%11%0%0%16294T16304C2%11%3%4%16126C16294T16296T4%8%0%0%16129A16311C16316G2%8%0%0%16209C16304C1%8%0%0%16260T16356C0%0%36%0%16051G16092C16129C16183C16189C16362C4%0%26%0%16129A16264T16311C0%0%15%4%16124C16189C16356A0%0%5%15%16189C2%0%0%12%1ThesedatademonstratesigniﬁcantgeneticdriftanddistinctpaternalandmaternallineageswithinPlaindemes.InourlocalAmishpopulation,the
16260T16356Chaplotypeaccountsfor36%ofHVR1haplotypes.Bygenealogicalanalysis,itcanbeshownthatallcopiesofthishaplotypewerederived
fromasingleancestralfemalewhomigratedtoPennsylvaniaintheeighteenthcentury.IntheGroffdaleMennonites,HVR116298C
16311Cpredominates(20%),whereas1669T
16126C16261TisthemostcommonhaplotypeamongtheWeaverlandMennonites(19%).Thirty-eightpercent
oftheJuniataandMifﬂinCountyAmishharbortheHVR1Cambridgereferencesequence.
disorders.This,alongwithinbreedingand
arestrictedfounderpool,hasbeentakenas

evidenceoflowgeneticdiversity.However,

microsatellitemarker(50)andSNPdata

challengethisview.UsingAffymetrix10K

GeneChiparrays,wefoundthatcalculated

heterozygosityacross9833autosomalSNPs
was33.7%and34.8%forAmish(N
=80)and
Mennonite(N
=80)individuals,respectively.
Thesevaluesaresimilartothe35.5%measured

inanEuropeancontrolpopulation(thesedata

refertotheAffymetrixEuropeancontrolsetfor

the10Karrays;fromAffymetrix,SantaClara,

CA).Thecomparisonsmaybeaffectedbydrift,
www.annualreviews.org
•Genetics,Medicine,andthePlainPeople517
 ANRV386-GG10-23ARI29July200915:38
whichcanleadtoalleleﬁxation.AmongMen-
nonites,351SNPsaremonoallelic;233ofthese

arealsomonoallelicintheEuropeancontrol

population.Thus,118(i.e.,351–233)SNPal-

leleshavebecomeﬁxedintheMennonitepop-

ulation,whereas204differentSNPalleleshave

reachedﬁxationintheAmish.
FurtherinspectionofSNPallelefrequen-
ciesshowsthatAmishandMennonitepopu-

lationsaregeneticallydissimilar.Wecompared

10095SNPsforsigniﬁcantallelefrequencydif-
706050403020
106050403020
106050403020
10abcMennonite vs. EuropeanAmish vs. EuropeanAmish vs. MennonitePercentageNumber of SNPs
19075014931.97.414.8Chromosome number
SNP X2 value
SNP X2 valueSNP X
2 value
246810
000121416182022
ferences(chi-square
>10.828,alpha
=0.001)amongLancasterCountyAmish,Lancaster

CountyMennonites,andtheAffymetrixEu-

ropeancontrolset.AmishandMennonitesam-

plesweremoresimilartoEuropeancontrols

thantoeachother(
Figure2
).Thissignif-
icantﬁndingunderscorestheimportanceof

choosingpropercontrolgroupsforassociation

andlinkagemappingstudies(
Figure3
)(65).
Itisalsorelevanttoclinicalwork;wehave

longappreciatedthatgeneticdiseasesofAmish

andMennonitepopulationsarequitedistinct

(Table3
)(59,65).Ofthe67disorderswede-
lineatedamongthePennsylvaniaAmishand

Menonnitepeople,onlyﬁvearefoundinboth

populationsandonlytwosharethesamemolec-

ulardefect.Thus,foranyparticularchildwho

presentswithamedicalproblem,thegenetic

differentialdiagnosisdependscriticallyonpop-

ulationoforigin(59).
Randomgeneticdriftisacompellingand
parsimoniousexplanationforallelefrequency
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−Figure2
Single-nucleotidepolymorphism(SNP)allele
frequenciesarehighlydissimilarbetweenOldOrder

AmishandMennonites.Weperformeda
2analysisofallelefrequenciesfor10095SNPsfromthe

AffymetrixGeneChipHumanMapping10KArrays.

Weused80Amishand80Mennonitefemalesand

performedtheanalysiswithhighcut-offvalues

(2>10.828,alpha
=0.001).Wealsocompared
thetwoPlainpopulationswithAffymetrixEuropean

controls.Genome-wideSNP
2valuesareplotted
inpanels(
a),(
b),and(
c)tohighlightoverall
differences.(
a)TheMennonitepopulationwas
moderatelydissimilartotheEuropeancontrols.

OnehundredninetySNPs(1.9%)demonstrated

statisticallysigniﬁcantdifferencesbetweenthesetwo

groups.(
b)TheAmishdemonstratedgreaterallele
frequencydifferences;roughly7.4%ofSNPs

exhibitedsigniﬁcantdifferenceswithEuropean

controls.(
c)TheAmishandMennonitecomparison
wasmoststrikingasnearly1in7SNPsshowed

signiﬁcantallelefrequencydifferences.Wesurmise

thattheselargedifferencesareduetogeneticdrift

withineachpopulation.SincetheAmishfounding

populationwassmaller,weexpectlargershiftsdue

todriftovertime.Thisisevidentbythecomparison

withEuropeancontrols,wheretheAmishshowa

nearlyfourfoldincreaseinallelefrequency

differencesascomparedtotheMennonites.
518Strauss
·Puffenberger
 ANRV386-GG10-23ARI29July200915:38
shiftswithinasmall,isolatedpopulation.How-
ever,allelefrequenciesmighthavebeenshaped

byselectionaswell.Forexample,Anabaptist

settlerswereexposedtonewpathogensthat

likelyexertedsigniﬁcantselectivepressures.

Althoughdifﬁculttomeasure,allelefrequency

shiftspointtointerestinggenecandidates.

FromourGeneChip10Kgenotypedata,the

SNPrs1986710demonstratesthelargestallele

frequencydifferencesbetweenPlainpopula-

tionsandtheAffymetrixEuropeancontrols

andHapMapdatasets.TheAallelefrequency

is94%inAmishand96%inMennonites,

comparedto54%inAffymetrixEuropean

controls.ThisSNPresideswithinanintronof

LPAR1,
ageneassociatedwithimmunityand
inﬂammation.Whencomparedtocontroldata(Americans
ofEuropeandescent),AmishandMennonite

samplesareskewedtowardlargerblocksof

homozygousSNPs(
Figure4
).Withinany
isolatedpopulation,homozygousmarkersthat

occurin“runs”orblocksarelikelyautozygous

(identical-by-descent);i.e.,boththematernal

andpaternalallelesderivefromacommon

ancestor.Now,wecanusemicroarraydatato

quantifythis—thegenome-wideestimateofau-

tozygosityis4.1%and2.5%inAmishand

Mennoniteindividuals,respectively.Similares-

timatesbasedonhomozygousmegabasesofge-

nomicDNAyieldcomparableresults(3.9%

and2.4%).ThisimpliesthattheaverageAmish

individualharbors
120Mbofautozygous
DNA.Theprobabilitythatanytworandom

Amishindividualswouldbeautozygousforthe

samegenomicregionandthesamehaplotype

isveryremote.Relativelyhighgeneticdiversity

andlowallelesharinghelpfacilitatesuccessful

autozygositymappingstudies,evenwithvery

smallsamplesizes.
ModernDiseaseGeneMapping
Large-scaleSNPgenotypingmethodologies

areamajortechnologicalbreakthroughbecause

theyallowsimultaneousandrapidgenotyping

ofmanymarkersrandomlydistributedacross

theentiregenome.Thisreducesanalyticaltime
Chromosome number
246810121416182022X
SNP X2 value
SNP X2 value
GCDH
06050403020100605040302010abFigure3
Population-speciﬁcSNPallelefrequenciesarecriticalforassociationmapping
withinPlainpopulations.Asatestcase,weanalyzedSNPproﬁlesof30Amish

childrenwithglutaricaciduriatype1(GA1),whowereallhomozygousfor

GCDHc.1262C>T.The
GCDHgenemapstoaregionofchromosome19that
haspoorSNPcoverageonGeneChip10Karrays,makinghomozygosity

mappingimpossible.Asanalternative,weattemptedtomapthediseaseusing

X2analysisofSNPallelefrequencydifferencesbetweenaffectedchildrenand
controls.Thisanalysisdependsonaccuratecontrolallelefrequenciesaswellas

extendedlinkagedisequilibriumsurroundingthediseasegene.Whenwe

comparedaffectedGA1childrentoOldOrderAmishcontrols,weeasily

identiﬁedthelocationof
GCDH.However,whenweusedOldOrder
Mennoniteallelefrequencydata,backgroundnoiseincreasedandthemapping

signalonchromosome19wasobscured.
andcost,andallowsautozygosityanalysistobe
donewithfeweraffectedpatients.Withsuf-

ﬁcientlydenseSNPcoverage,itisnolonger

necessarytoinfergenotypeandhaplotypeshar-

ingbetweendistantmarkers;increasedmarker

densityprovidesenoughinformationtoreveal

sharingdirectly.Highermarkerdensityalso

simpliﬁesanalysis.Largesharedblocksofho-

mozygousSNPscanbedetectedwithsimple

countingandgraphingalgorithmsusingstan-

dardspreadsheetsoftware(67,90).Wehave
www.annualreviews.org
•Genetics,Medicine,andthePlainPeople519
 ANRV386-GG10-23ARI29July200915:38
Table3Thirty-sevenAmishand29MennonitedisordersunderstoodatthemolecularlevelamongdemesofPennsylvania,
Ohio,andMaryland
DisorderGeneDNAVariant
ProteinVariant
PopulationDeme3-methylcrotonylglycinuriaMCCC2295G>CGlu99GlnAmishA3-ß-OH-steroiddehydrogenase
deﬁciencyHSD3B235G>AGly11GluAmishAAldosteronedeﬁciency
CYP11B25bpdeletion
AmishAAmishmicrocephaly
SLC25A19530G>CGly177AlaAmishABardet-Biedlsyndrome
BBS11169T>GMet390ArgAmishABarttersyndrome
CLCNKBgenedeletion
AmishA,B
Cardiomyopathy,dilated,withAV
blockLMNA568C>TArg190Trp
AmishACartilage-hairhypoplasia
RMRP70A>GAmishA,O
Corticaldysplasiaandfocalepilepsy
CNTNAP23709delGAmishA,B,O
Crigler-Najjarsyndrome
UGT1A1222C>ATyr74Ter
AmishAEllis-vanCreveldsyndrome
EVCIVS13+5G>TAmishAFamilialhypercholanemia
BAAT
226A>GMet76Val
AmishAFamilialhypercholanemia
TJP2143T>CVal48Ala
AmishAGalactosemiaGALT
563A>GGln188ArgAmishA,E
Gittelmansyndrome
SLC12A31924C>AArg642GlyAmishA,B
Gittelmansyndrome
SLC12A38627bpdeletion
AmishA,B
Gutaricaciduria,type1
GCDH1262C>TAla421Val
AmishAGutaricaciduria,type3
C7orf10895C>TArg299Trp
AmishA,B
McKusick-Kaufmansyndrome
MKKS[250C>T+724G>T]His84Tyr/Ala242Ser
AmishANemalinerodmyopathy
TNNT1505G>TGlu180Ter
AmishANephroticsyndrome
NPHS2413G>AArg138GlnAmishAOsteogenesisimperfecta
COL1A22098G>TGly610CysAmishAPelizaeus-Merzbacher-likesyndrome
GJA12203A>GTyr68Cys
AmishAPhenylketonuriaPAH
280-282delATC
AmishAPhenylketonuriaPAH
782G>AArg261GlnAmishAPropionicacidemia
PCCB1606A>GAsn536AspAmishA,B
Severecombinedimmunedeﬁciency
RAG12974A>GLys992Glu
AmishASitosterolemiaABCG81720G>AGly574ArgAmishAWeil-Marchesanisyndrome
ADAMTS1015exondel
AmishAChronicgranulomatousdisease
CYBB1335C>ACys445Ter
AmishETroyersyndrome
SPG201110delAAmishO11-hydroxylasedeﬁciency
CYP11B11343G>AArg448HisAmishBAdenosinedeaminasedeﬁciency
ADA646G>AGly216ArgAmishBBylerdisease
ATP8B1
923G>TGly308Val
AmishBCockaynesyndrome
ERCC6IVS14+1G>TAmishBGM3synthasedeﬁciency
ST3GAL5694C>TArg232Ter
AmishB,O
Primaryciliarydyskinesia
DNAH54348C>TGln1450Ter
AmishBPyruvatekinasedeﬁciency
PKLR1436G>AArg479HisAmishBSuddeninfantdeathwithdysgenesisof
thetestes
TSPYL1457458insGAmishBHomocystinuriaMTHFR1129C>TArg377CysAmishJ(Continued)520Strauss
·Puffenberger
 ANRV386-GG10-23ARI29July200915:38
Table3(
Continued)DisorderGeneDNAVariant
ProteinVariant
PopulationDeme3-methylcrotonylglycinuriaMCCC2518insTMennoniteM,X
Alpha-1antitrypsindeﬁciency
SERPINA11096G>AGlu342Lys
MennoniteMBiotinidasedeﬁciency
BTD1459T>CTrp487Arg
MennoniteMCongenitalnephroticsyndrome
NPHS11481delCMennoniteMCongenitalnephroticsyndrome
NPHS13250delGMennoniteMCrigler-Najjarsyndrome
UGT1A1222C>ATyr74Ter
MennoniteMCystinuriaSLC3A1IVS6+2T>CMennoniteMCystinuriaSLC3A11354C>TArg452Trp
MennoniteMCystinuriaSLC7A9201C>TIle67IleMennoniteMCystinuriaSLC7A91166C>TThr389MetMennoniteMDeafness,nonsyndromic
GJB235delGMennoniteMFactor11deﬁciency
F111327C>TArg443CysMennoniteMFragileXsyndrome
FMR1(CGG)nexpansion
MennoniteMGlycogenstoragedisease,type6
PYGLIVS13+1G>AMennoniteMHirschsprungdisease
EDNRB828G>TTrp276Cys
MennoniteM,S
LYK5deﬁciency
LYK5
7304bpdeletion
MennoniteMMaplesyrupurinedisease
BCKDHA1312T>ATyr438Asn
MennoniteM,S
Medium-chainacyl-CoA
dehydrogenasedeﬁciency
ACADM985A>GLys329Glu
MennoniteMMedium-chainacyl-CoA
dehydrogenasedeﬁciency
ACADMIVS4-30A>GMennoniteMMevalonatekinasedeﬁciency
MVK803T>CIle268ThrMennoniteMMevalonatekinasedeﬁciency
MVK1174G>AAla392ThrMennoniteMPhenylketonuriaPAH
IVS12+1GAMennoniteMPhenylketonuriaPAH
782G>AArg261GlnMennoniteMPropionicacidemia
PCCB1606A>GAsn536AspMennoniteM,S
Restrictivedermopathy
ZMPSTE245455insTMennoniteMSeverecombinedimmunedeﬁciency
IL7R2T>GMennoniteMSpinalmuscularatrophy
SMN1exon7deletion
MennoniteMTyrosinehydroxylasedeﬁciency
TH698G>AArg233HisMennoniteMTyrosinemia,type3
HPD85G>AAla29ThrMennoniteMVitaminB
12deﬁciencyAMN44bpdeletion
MennoniteMProperdindeﬁciency
PFC379T>GCys127GlyMennoniteXOsteoporosis-pseudogliomasyndrome
LRP51225A>GThr409AlaMennoniteSOsteoporosis-pseudogliomasyndrome
LRP51275G>ATrp425Ter
MennoniteSPhenylketonuriaPAH
IVS10-11G>AMennoniteSCardiomyopathy,hypertrophic
SLC25A4523delCMennoniteWPeriodicfever(TRAPS)
TNFRSF1A362G>AArg121GlnMennoniteWSalladisease
SLC17A5115C>TArg39CysMennoniteWTyrosinemia,type3
HPD479A>GTyr160Cys
MennoniteWTyrosinemia,type3
HPD1005C>GIle335MetMennoniteWA,LancasterCounty(PA)Amish;B,JuniataandMifﬂinCounty(PA)Amish;O,HolmesandGeaugaCounty(OH)Amish;J,SomersetCounty(PA)
Amish;M,WeaverlandandGroffdaleConferenceMennonites(PAandelsewhere);S,StaufferMennonites(PA/MD);W,WesternMD;X,other

unspeciﬁedMennonites;E,easternshoreofMarylandAmish.
www.annualreviews.org
•Genetics,Medicine,andthePlainPeople521
 ANRV386-GG10-23ARI29July200915:38
abAverage number of blocks
Deviation from control
201510Ð5Ð10Ð15Ð20Ð25Ð30Ð35Ð40AmishMennonite

Control
Block size
21-3031-4041-5051-6061-7071-8081-9091-100
>100AmishMennonite
Block size
222222426282
102122142
162182202654321050Figure4
Plainpopulationsdemonstrateincreasesinhomozygousblocksizeandnumber
comparedtoAmericansofEuropeandescent.Blocksofhomozygositywere

quantiﬁedbytheirSNPcontentandphysicalsize.(
a)Theaveragenumberof
homozygousSNPblocksperpersonisshown.AmishandMennonite

individualshavemore(andlarger)runsofhomozygositythandocontrols.

(b)Theﬁgureplotsdeviationsfromtheaveragecontrolblockdatabysize(i.e.,
numberofSNPscontainedineachhomozygousblock).ThePlainpopulations

arerelativelydeﬁcientinsmallhomozygousruns,whicharereplacedbylarger

blocks.Theexcessrunsofhomozygosityrangeinsizefromabout20toover

200adjacentSNPs(
highlightedarea
).ForeachPlainpopulation,excess
homozygosityrelativetoEuropeancontrolsisfoundinarelativelysmall

numberoflargeblocks,comprisingroughly116.7and72.5Mbofhomozygous

DNAinAmishandMennonitegenomes,respectively.
usedthesetechniquestomapdisorderswithas
fewastwoaffectedchildren(89).
Wehaveappliedvariousmethodstoiden-
tify75differentmutationssegregatinginthe

PlainpopulationsofsoutheasternPennsylva-

niaandelsewhere.Themoststraightforward

methodiscandidategeneanalysis—sequencing
acandidategeneknowntocauseapheno-
type.Phenylketonuriamutationsinseveral

unrelatedOldOrderAmishpatientsfromLan-

casterCountywereidentiﬁedinthisway,and

thesamestrategywasappliedtodisorders

suchas5,10-methylenetetrahydrofolatereduc-

tase(MTHFR)deﬁciency,factorXIdeﬁciency,

andCrigler-Najjarsyndrome.
Arelatedapproach,candidategenelocal-
ization,usesSNPdatatonarrowalistof
candidategenesthatareassociatedwitha

particularphenotypeandscatteredacrossthe

genome,providedthechildisautozygoussur-

roundingthediseasegenelocus.Bycorrelating

homozygousblockstothelocationofcan-

didategenes,wecanoftenidentifyasingle

genefortargetedsequencing.Thismethodhas

beenusedsuccessfullytomapautosomalreces-

sivedeafness,Cockaynesyndrome,megaloblas-

ticanemia,andhereditaryspasticparaplegia

(Figure5
).Finally,diseasegenemappingusesgenetic
markerdatatomapunknownrecessivepheno-

typesbycomparinghomozygousblocksamong

multipleaffectedindividuals(67,68,89,90).

Thisstrategyexploitsgeneticpropertiescom-

montoyoungpopulationswithasmallnumber

offounders,andalsoassumesmutationhomo-

geneity.Weoftendelineatelocusboundaries

rapidlyandefﬁciently,butthesharedhomozy-

gousblockstendtobequitelarge.Theaverage

sharedblockis6.3Mb(mean3.7patientsper

study)andcontainsdozensandsometimeshun-

dredsofgenes.Thus,althoughﬁndingtherele-

vantblockcanbesimple,identifyingthedisease

genewithinitcanbedaunting.
Wehaveinitiatedover40separatege-
neticmappingstudiesinPlainpopulationsof

Pennsylvania,Maryland,Indiana,andOhio.

For14ofthese,weunequivocallymappedthe

diseasegeneandidentiﬁedthepathogenicse-

quencevariant.For10others,wedelineated

achromosomalregionbuthaveyettoidentify

thecausativegene(
Table4
).Fortheremainder,
mappingresultsareinconclusiveduetoinsuf-

ﬁcientsamplesizeorthepresenceofmultiple

sharedhomozygousblocks.
522Strauss
·Puffenberger
 ANRV386-GG10-23ARI29July200915:38
LocusLocation
Number of homozygous SNPs
Location score
25151050353020SPG201q242q37
3q27
6q23
8p12
10q22
13q13
13q14
14q
14q21
14q23
15q14
15q21
16q24SPG23SPG30SPG14SPG25SPG5ASPG27SPG20SPG24SPG32SPG28SPG15SPG11SPG21SPG7SPG5BSPG35Chromosome number
Homozygous block size
246810121416182022
Figure5
TwobrothersfromaMidwesternAmishdemepresentedtoourclinicwithdevelopmentaldelay,short
stature,andsymmetricspasticdiplegia.Recessivehereditaryspasticparaplegia(SPG)wasconsideredinthe

geneticdiagnosis,butareviewof
OnlineMendelianInheritanceinMan
revealedmultipleSPGlociscattered
throughoutthegenome.Thisdauntinggenelistwouldlikelyprecludefurthergenetictesting.However,

assumingidentity-by-descentforthediseasegene,weused10KSNPdatatoexcludethelargemajorityof

SPGlociandshowthatbothboyswerehomozygousforalargeblockofDNAsurroundingthelocusfor

Troyersyndrome(SPG20);sequencingconﬁrmedhomozygosityfortheknownsingle-base-pairdeletion

(1110delA)in
SPG20.MENDELIANDISORDERS
INPLAINPOPULATIONS
TheEvolutionofClinicalMethods
Amishgeneticstudiesbetween1964and1988
predatedtheeraofmolecularmappingand

didnotdealexplicitlywiththeproblemof

providingcare.Manyresearchsubjectsdied

orwerecrippledbecausetheylackedappro-

priatemedicalservices(57).In1989,Holmes

andCarolineMortonestablishedthesmall

nonproﬁtClinicforSpecialChildrentoserve

AmishandMennonitechildrenwhosuffered

fromgeneticdisorders(7,8).TheClinicwas

sitedinruralLancasterCounty(
Figure6
),whichgavefamiliesnearbyaccesstoaffordable

care(60)andprovidedaframeworkforstudy-

inggeneticdisordersinanaturalsetting(41,

45).Itisaparadigmofcommunitygenetics

(46),designedtoserveparticularpeopleliving
inaspeciﬁcplaceandtime(15,57,59,65).The

OldOrdercommunitiessupporttheworkasa
waytocarefortheirown(8,59).Today,Clinic
staffmanage1029activepatientsrepresenting

over105differentMendeliandisorders.
FromtheClinic’sinception,on-sitelabo-
ratorystudieswerecontinuallyshapedbythe

needsofpatients;researchandclinicalcare

wereinseparable.Between1989and1993,a

gaschromatograph-massspectrometerdonated

byHewlett-Packardwasusedtoscreen1232

Amishchildrenforglutaricaciduriatype1

(GA1)(58).In1990,twoMennonitechurches

donatedahigh-performanceliquidchromato-

graphthathasrunmorethan17,000aminoacid

samplesforthediagnosisandmanagementof

maplesyrupurinedisease(MSUD)(59).Inthe

earlyyearsoftheClinic,operatingthesein-

strumentsonthefrontlineofclinicalpractice

meantthatGA1couldbediagnosedwithina

fewhoursoflife(i.e.,fromamnioticﬂuidob-

tainedatdelivery)(58),andMSUDcouldbe

detectedinasymptomaticnewbornslessthan

1dayold(60).Thesemethodswereacrucial
www.annualreviews.org
•Genetics,Medicine,andthePlainPeople523
 ANRV386-GG10-23ARI29July200915:38
Table4Twenty-threegeneticdisordersmappedusingSNPmicroarraysattheClinic
forSpecialChildrensince2003.ThecausativegenewasidentiÞedfor14conditions,

whereas9otherdisordersaremappedtoaregionbutthegeneremainsunknown
DiseaseChromosomeGeneNephroticsyndrome,Amish
1NPHS2Pelizaeus-Merzbacher-likesyndrome
1GJA12Barttersyndrome
1CLCNKBHypertrophiccardiomyopathy
4SLC25A4Primaryciliarydyskinesia
5DNAH5Suddeninfantdeathwithdysgenesisofthetestes
6TSPYL1Salladisease
6SLC17A5Corticaldysplasiaandfocalepilepsy
7CNTNAP2Glutaricaciduria,type3
7C7orf10Severecombinedimmunedeﬁciency
11RAG1Deafness,Mennonite
13GJB2Gitelmansyndrome
16SLC12A3Polyhydramnios,megalencephaly,andsymptomaticepilepsy
17STRADAWeil-Marchesanisyndrome
19ADAMTS10Posteriorcolumnataxiawithretinitispigmentosa
1Congenitalnystagmus
1Usher-likesyndrome
5Hydrocephalus6Lethalseizuresyndrome
7Mentalretardation,nonsyndromic
12Junctionalectopictachycardia
15Spasticparaplegia
15“Yoder”dystonia
15“Schwartz”syndrome
20Microcephaly22ﬁrststeptowarddiseaseprevention,allowing
affectednewbornstostarttherapydaysbefore

statescreeningresultswerecomplete.
In1999webegandirectDNAsequencing,
whichledquicklytomutationidentiﬁcation

fornumerousdisordersandcarriertestingfor

GA1,MSUD,andseveralotherconditions(58,

60,83,91).AffymetrixdonatedaGeneChip

scannerin2005.Itprovedapowerfultool

formapping(67,88,89)andalsorevealed

importantdetailsaboutalleledynamicswithin

Plainpopulations.In2007,weacquireda

Rochereal-timePCRsystem(LightCycler)

throughcharitablecontributionsfromthe

A.J.StampsFoundationandCSLBehring.
Thisinstrumentusesmeltingcurveanalysis
todetectmutationsinaboutanhour(94).It

isidealforcommunity-basedgenetictesting

[seesidebar1,5,10-Methylenetetrahydrofolate

Reductase(MTHFR)Deﬁciency]andcanbe

adaptedtopracticalclinicalproblemssuchas

low-resolutionHLAmatching(88).
SpectrumofMendelianDisease
Table3
lists29Mennoniteand37Amish
disordersunderstoodatthemolecularlevel,

restrictedforthepurposeofthisreviewto

populationsofPennsylvaniaandMaryland.Al-

thoughthereissomecrossover,demesofOhio,
524Strauss
·Puffenberger
 ANRV386-GG10-23ARI29July200915:38
Indiana,andelsewheresufferfromdifferent
geneticdisorders.EvenwithinPennsylvania,

thereareseveralgeneticallydistinctgroups,

andthesedistinctionsareclinicallyimportant

(seesidebar2,GeneticEpidemiology).
Ninetypercentoftheconditionslistedin
Table3
arerecessive,and90%oftheseresult
fromasingleallelerestrictedtoaparticular

deme(54,55).However,thereareseveral

exceptions.AmongOldOrderMennonites,

whostemfromalargerfoundingpopula-

tion,wehaveidentiﬁedmultiplemutations

forphenylketonuria,cystinuria,medium-

chainacyl-CoAdehydrogenasedeﬁciency,

mevalonatekinasedeﬁciency,osteoporosis-

pseudogliomasyndrome,andtyrosinemia

type3.AmongtheAmish,biotinidasede-

ﬁciency,galactosemia,Gitelmansyndrome,

andphenylketonuriademonstratemutation

heterogeneity,andfamilialhypercholanemia

exhibitslocusheterogeneity.
Althoughmostofthedisorderswemanage
arerecessive,wehavealsoidentiﬁedseveralX-

linked(e.g.,fragileXsyndrome,chronicgranu-

lomatousdisease,andproperdindeﬁciency)and

dominantconditions(e.g.,
LMNAcardiomy-opathyandpolycystickidneydisease),and

recognizeothersyettobemapped(sympha-

langism,multipleexostoses,arteriovenousmal-

formation).Althoughfewerinnumber,these

disordersneverthelessexactaheavytollwhen

theyoccurinlargeextendedfamilies.Wehave

alsofounddenovomutationsinachildwith

lissencephaly(
PAFAH1B1
deletion),achild
withApertsyndrome(
FGFR2),anadultwith
idiopathictorsiondystonia(
DYT1),andsev-
eralchildrenwithPrader-WilliorAngelman

syndrome(chromosome15deletions).Finally,

using10KSNParrayswehaveidentiﬁedchro-

mosomalabnormalitiesattheresolutionofa

standardkaryotypeinnumerouschildrenwith

syndromicdevelopmentaldelay(
Figure7
).Althoughcertainmutationsareconcen-
tratedinAmishandMennonitedemes,they

areseldomuniquetothesegroups.About

20%ofindividualsleavetheOldOrdereach

generation,allowingmutationstoﬂowinto
Figure6
TheClinicforSpecialChildrenissitedonanuntillablecorneroffarmlandin
ruralLancasterCounty,Pennsylvania.ThelandwasthegiftofanAmishman

whohastwogranddaughterswithglutaricaciduriatype1.Itwasbuiltwiththe

donatedlaborofAmishandMennoniteworkers.TheClinicisreadilyaccessible

tomostofitspatientsandhason-sitebiochemicalandmoleculartesting.
SIDEBAR1.
5,10-METHYLENETETRAHYDROFOLATE

REDUCTASE(MTHFR)DEFICIENCY
AnAmishboy,borninSomersetCountyin1998,hadpsychomo-
tordelayandslowheadgrowthby3monthsofage,andanMRI

showedglobalcerebralatrophyandhypomyelination.Hewas

seenbynumerouspediatricsubspecialistsbutremainedwithout

adiagnosisaftermorethan$10,000ofdiagnostictesting.We

sawhiminOctober2003,andbasedonabiochemicalworkup

identiﬁedapathogenic1129C
>Tchangein
MTHFR(87).De-
spitetreatmentwithhigh-dosebetaine,heremainedseverelyre-

tarded,autistic,andmute.WemadeseveralﬁeldtripstoSomer-

setCountywhereweidentiﬁed68
MTHFRc.1129C>Tcarriers
among230healthymembersofthedeme(estimatedpopulation

carrierfrequency30%).IncollaborationwithDr.Naylorand

hiscolleagues,wedevelopedaLightCyclermethodfordetecting

MTHFRc.1129C>Tindriedﬁlterpaperbloodspots(28).Mid-
wivesofferedAmishparentstheoptionofgettinga“ﬁfthblood

spot”totestforthe
MTHFRmutation.Theﬁrstnewborndiag-
nosedbyLightCyclerscreeningin2004wassistertotheproband

(87).Shestartedtherapyduringhersecondweekoflifeandhas

nosignsofbraindamageafterfouryearsoffollow-up.
www.annualreviews.org
•Genetics,Medicine,andthePlainPeople525
 ANRV386-GG10-23ARI29July200915:38
SIDEBAR2.GENETICEPIDEMIOLOGY
MostAmishbabiesaredeliveredathome,breastfeed,anddonot
receiveparenteralvitaminK.InLancasterCounty,tworecessive

allelesintheAmish(
TJP2c.143T>Cand
BAAT
c.226A>G)dis-
ruptbilesaltmetabolismandresultinvitaminKmalabsorption

(20).Thusgeneticfactorsinteractwithculturalpracticetodeter-

mineactualrisk:overthepast10years,threeAmishinfantswith

bilesaltdisorderspresentedwithmassiveintracerebralandretinal

hemorrhagesfromvitaminKdeﬁciency.Onechildsurvivedwith

densespastichemiparesisandunilateralblindness.Theothertwo

diedofacutebraininjuries.Inonecase,theparentswerewrong-

fullyaccusedofchildabuseandtemporarilylostcustodyoftheir

otherchildren.Screeningforbilesaltdisordersandneonatalvita-

minKadministrationarepressingpublichealthconcernsagainst

thisgeneticbackground.InJuniataandMifﬂinCounties,amu-

tationin
TSPYL(457458insG)amongAmishchildrencauses
braindiseaseandadysautonomiasyndrome(SIDDT)thatac-

countsfor20%ofoverallinfantmortalityandperhapshalfof

allsuddeninfantdeathsintheregion(67).Topreventsudden

infantdeathinMifﬂinCounty,effortstounderstandandtreat

SIDDTsyndromeareatleastasimportantasthe“backtosleep”

campaign(
http://nichd.nih.gov/sids/).theoutbredpopulation(59).Moreover,most
pathogenicallelesprobablyexistedinEurope

beforetheAnabaptistmigration.Forexample,

allfourPlainmutationsofthe
PAH
genewere
ﬁrstidentiﬁedinEuropeanswithphenylke-

tonuria(
Table3
),andtheonly
GCDHvariantknowntocauseglutaricaciduriatype1inthe

Amish(c.1262C
>T)isamongthemorecom-
monmutationsfoundthroughoutEuropeand

theUnitedStates.Curiously,severalfounder

mutationsfromFinlandarealsodistributed

inNorthAmericanPlainsects(i.e.,
RMRPc.70A>Gand
SLC17A5c.115C>T).Thereare
noknowngenealogicaltiesbetweenSwissAn-

abaptistsandFinns,suggestingthatthesemu-

tationsareeitherancientorrecurrent(51).
For21(31%)conditionslistedin
Table3
,anexperiencedcliniciancanmakeacorrect

diagnosisbasedontheclinicalpresentation

andasingleconﬁrmatorytest.Afewoth-

ersaredistinctiveandeasilyrecognized(e.g.,
Amishlethalmicrocephaly,Ellis-vanCreveld
syndrome,Weil-Marchesanisyndrome,etc.).

Only8(12%)arereliablydetectedbystate

newbornscreening.Importantly,about40%

ofthedisorderscannotbediagnosedbyrou-

tineclinicalmethods;theypresenttophysi-

ciansasnonspeciﬁcproblemssuchasfailure

tothrive,jaundice,bruising,itching,develop-

mentaldelay,cerebralpalsy,mentalretardation,

autism,seizures,shortstature,orweakness.An

understandingofgeneticriskswithinapopu-

lationmakesitclearthatthesegeneralterms

applytomanydiscretecauses(
Table5
)(see
sidebar3,Glutaryl-CoADehydrogenaseDeﬁ-

ciency).Thesameislikelytrueinoutbredpop-

ulations,butitismuchhardertoinvestigate.
Whenweencounteranovelphenotype,in-
vestigationalstudiesareneededtodetermine

themolecularcauseandthentranslatethisin-

formationintousefulclinicaltesting(67,68,

90).ManycoregeneticlaboratoriesofferDNA

isolationandstorageaswellasbiochemicalge-

neticstesting.However,fewoffertheﬂexible

genotypingandsequencingservicesneededto

mapanewdisease.Fewerstillachievethese

aimswithinaclinicallyrelevanttimeframeor

atanacceptablecosttoself-payfamilies.Our

laboratoryfunctionsasaspecializedcorefa-

cilitywiththesolepurposeofsolvingpatient-

andcommunity-centeredproblemsquicklyand

economically(88).Wehavemovedthetoolsof

geneticresearchtotheclinicallaboratoryand

investedheavilyintheircontinueduseandef-

ﬁcacy.Consequently,whenevaluatinganew

patientweareaslikelytosequenceageneor

generateSNPgenotypesaswearetoorderan

electrolyteproﬁle.
TRANSLATIONALMEDICINE
ANDTHETREATMENT

OFGENETICDISEASE
TreatmentofGeneticDisease
Justover20yearsago,halfofknowngenetic
disorderswereconsidereduntreatableandonly

about10%couldbetreatedinahighlyeffective
526Strauss
·Puffenberger
 ANRV386-GG10-23ARI29July200915:38
manner(93).Wehaveseenextraordinary
progressinPlainpopulationsoverthepasttwo

decades.Forabout40%ofthedisorderswe

manage,simpledietaryinterventionhasadeci-

siveeffect.Theseincludeconditionssuchasbi-

otinidasedeﬁciency,galactosemia,andvitamin

B12malabsorption.Protocolsforthetreatment
ofmaplesyrupurinedisease(MSUD),Crigler-

Najjarsyndrome,andseverecombinedimmune

deﬁciency(SCID)aremorecomplexbutstill

quiteeffective(2,57,60,91).Theselattercon-

ditionscannowbecuredbytissuetransplant,

currentlytheonlyreliableformofgenetherapy

(85,91).Problemssuchaspyruvatekinasede-

ﬁciency,cystinuria,anddeafnessaretreatable,

butnotperfectlyso.Nevertheless,likediabetes,

depression,andcancer,skillfulmedicalcareal-

lowspeopletolivelonger,sufferless,andenjoy

moreindependence.
For13(21%)geneticconditionslistedin
Table3
,eventualoutcomeisnotaffectedby
treatment;ﬁveofthesedisordersarelethaldur-

inginfancy.Theyareamongthemostcommon

geneticdisordersweencounter;amongthe
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−Figure7
AffymetrixGeneChipHumanMapping10KArrays
areusefulforcopy-numberassessment.Although

the10Karrayslackﬁneresolutionforthis

application,ourdatashowthattheyperformatleast

aswellasastandardkaryotype.Wereadilyidentify

copy-numberabnormalitiesinthe2–4Mbrange,

validatedbystandardmetaphasekaryotype

(http://www.mayomedicallaboratories.com/
).Ouranalysesusethecopy-numberdatagenerated

bytheAffymetrixGenotypesoftware.Wecalculate

meanandstandarddeviationsfortheﬂuorescenceat

eachSNPmarkerandthengenerateZscoresforthe

patientateachSNPmarker.Thispartiallycorrects

forpolymorphiccopy-numbervariationwithinthe

genome.Panels(
a)and(
b)showtwosmalldeletions
of4.1and
4.2Mb,respectively.Theﬁrstpatient
hadmultiplecongenitalanomalies,andthesecond

patientwasdiagnosedwithAngelmansyndrome

afterSNPanalysisdetectedmonosomyon

chromosome15.Panels(
c)and(
d)depicttrisomyof
chromosome2qmarkersandacomplex

rearrangementinvolvingpartialdeletionand

duplicationofchromosome8.Datainpanels(
b)and
(d)arefrommales,andhemizygosityforX
chromosomemarkersisapparent.
Amish,forexample,wehavearecordof85chil-
drenwithlethalmicrocephalybornbetween

1960and2008and88childrenbornwithne-

malinerodmyopathy(
TNNT1)since1989
9630Ð3Ð69630Ð3Ð69630Ð3Ð69630Ð3Ð6cadbChromosome number
246810121416182022X
SNP copy number Z score
SNP copy number Z score
SNP copy number Z score
SNP copy number Z score
www.annualreviews.org
•Genetics,Medicine,andthePlainPeople527
 ANRV386-GG10-23ARI29July200915:38
SIDEBAR3.GLUTARYL-CoA
DEHYDROGENASEDEFICIENCY
Before1989,AmishchildrenwithGA1werecommonlymisdi-
agnosedwithcerebralpalsyoracuteviralencephalitis.Theﬁrst

geneticstudyattheClinicforSpecialChildrenidentiﬁedGA1

asthecauseof“Amishcerebralpalsy”in16disabledchildren

whotracedtoasinglefoundingcouple(58).Beginningin1989,

theClinicofferedamnioticﬂuidandurineorganicacidscreening

fornewborns,comprehensivepediatricfollow-upcare,andinpa-

tientmanagementforillnesses.Dr.Naylorintroducedstatewide

supplementalscreeningforGA1in1994.Between1989andthe

present,therateofbraininjuryinGA1decreasedfrom94%to

36%(83).ThustheefﬁcacyoftreatmentinGA1,aswithmany

geneticconditions,isrelative.AlthoughGA1isthemostcom-

monmimicofcerebralpalsyinLancasterCounty,otherhered-

itaryconditionscanproduceasimilarphenotypeand,equally

importantly,noteverychildwithdystoniahasaMendeliandis-

order.Acquiredcausesofbraininjuryareintermingledwith,and

difﬁculttodistinguishfrom,geneticdisease.
(43,59).Evenforsuch“untreatable”prob-
lems,medicalcareisimportant(57,59).Before

theClinicwasestablished,Amishchildrenwith

nemalinerodmyopathywererepeatedlysub-

jectedtoinvasiveandcostlyinterventions(e.g.,

musclebiopsies,nerveconductiontesting,elec-

tromyography,magneticresonanceimaging,

echocardiograms,etc.)thatcollectivelycostthe

communitymillionsofdollars.Athoughtful

physicianinformedwiththerightgeneticdi-

agnosiscanhelpafamilydetermineappropri-

atelimitsofmedicalcarewhilealsoprotecting

thechildfromfutileinterventionsandthecom-

monmiseriesofhunger,thirst,dyspnea,and

pain.PresymptomaticDiagnosis
andDiseasePrevention
Childrenborntodaywithconditionssuch
asGA1,MTHFRdeﬁciency,orMSUD—

oncethoughtuntreatable(39)—nowgrowup

healthyifdiagnosedearlyinlife(seesidebars1,

3,and4)(60,83,87).Presymptomaticdiagnosis

createsawindowofopportunity(22,33,40,83).
ThiswastheideabehindGuthrie&Susi’stest
forphenylketonuriainnewborns,publishedin

1963(36).Thirtyyearslater,shortlyafterDr.

MortonbeganhisworkinLancasterCounty,

EdwinNaylorandcolleagueswereusingtan-

demmassspectrometrytoscreennewbornsfor

amuchbroaderspectrumofgeneticconditions

(21).Screeningdoesnot,however,assuregood
outcome.Earlydiagnosisisofnovaluewith-

outapragmaticfollow-upplandesignedtodeal

withthedynamicinterplayamonggenes,envi-

ronment,anddiseaseasitunfoldsovertime.

Genesencodeproteinsembeddedincomplex

biologicalnetworks.Thesenetworksarecon-

tainedwithincells,groupedintotissues,and

abletointeractwithinphysiologicalsystems.

Understandingdisturbancesatalloftheselev-

els,asexperiencedbyintacthumansintheir

naturalsetting,isthebasisfordesigningeffec-

tivetherapies(38,70).Thisisvividlyillustrated

bythehistoryofMSUDinLancasterCounty

(59).Before1989,one-thirdofMennonitechil-
drenwithMSUDdiedduringchildhood.Most

whosurvivedwereseverelydisabled[seeside-

bar4,ChangingtheNaturalHistoryofMaple

SyrupUrineDisease(MSUD)](57,59,60).

SincetheClinicstartedofferinglocalservices,

outcomesforMSUDhaveimproved(60).No

childdiedwhileunderourcareformetabolic

crisis,andallMennonitechildrenwithMSUD

bornafter1988attainednormaldevelopmen-

talmilestones.Knowledgeofpathophysiology,

notgenetics,fueledthisprogress.Through

carefulstudyofmanyindividualsindiverse

clinicalcircumstances,welearnedhowdeﬁ-

ciencyofbranched-chainketoaciddehydrogen-

asedisruptscriticalbiologicalprocessessuchas

metabolicadaptationtofastingandillness(86),

cerebralaminoacidtransport(86,87),andcell

volumecontrol(60).Theseprocesseschange

withageandareinﬂuencedbymanynutri-

tionalandenvironmentalvariables.Ourtreat-

mentprotocolevolvedinlockstepwithourun-

derstandingofthiscomplexphysiology(60)and

allowedustopreventmanyseriousneurologi-

calconsequencesofMSUD.
528Strauss
·Puffenberger
 ANRV386-GG10-23ARI29July200915:38
Table5GenemutationsresultinspeciÞcmedicalconditionsthatareoftendescribedwith
nonspeciÞcterms:mentalretardation,cerebralpalsy,autism,suddeninfantdeath,sepsis,

andepilepsy
1Clinicaldiagnosis
DisorderGeneCerebralpalsy
Glutaricaciduriatype1
GCDHPropionicacidemia
PCCBGapjunctiondeﬁciency
GJA12Crigler-Najjarsyndrome
UGT1A1Hereditaryspasticparaplegia
SPG20Dopamine-responsivedystonia
THIdiopathictorsiondystonia
DYT1Mentalretardation
PhenylketonuriaPAH
MTHFRdeﬁciency
MTHFRMaplesyrupurinedisease
BCKDHASalladisease
SLC17A5Bardet-Biedlsyndrome
BBS1FragileXsyndrome
FMR1EpilepsyBiotinidasedeﬁciency
BTDCDFEsyndrome(CASPR2)
CNTNAP2GM3synthasedeﬁciency
ST3GAL5PMSEsyndrome
STRADAStroke/hemorrhageHypercholanemia,TJP2type
TJP2Hypercholanemia,BAATtype
BAAT
FactorVLeiden
F5SitosterolemiaABCG8Alpha-1-antitrypsindeﬁciency
SERPINA1Suddendeath
SIDDTsyndrome
TSPYL3-beta-HSDdeﬁciency
HSD3B2Hypertrophiccardiomyopathy
SLC25A4Lethalinfection
GalactosemiaGALT
Properdindeﬁciency
PFCSCID,IL7receptortype
IL7RAdenosinedeaminasedeﬁciency
ADARAG1deﬁciency,Omenn
RAG11ThistablelistsaselectionofgeneticsyndromesthatcausedevelopmentaldisordersinAmishandMennonite
children.Recognizinggeneticpredispositionsthatunderliesuchdisordersisakeysteptowardplanningeffective

preventionstrategies.
Diseasepreventionhassubstantialeco-
nomicrepercussions(57).Basedonourexpe-

riencewithMSUDandseveralothertreatable

geneticconditionsthataffectthenervous

system(
Table3
),wehavepreventedseveremo-
tordisabilityormentalretardationinanes-

timated150childrenovera20-yearperiod.
ThissavedthePlaincommunitiesabout
$180millionindirectandindirectcosts

(3).Thusannually,ouroperatingbudgetof

$1.4millionreducesthecommunityeconomic

burdenbyover$8million.
Tohelpuninsuredpatients,preventative
therapiesmustbeaffordable.Forexample,early
www.annualreviews.org
•Genetics,Medicine,andthePlainPeople529
 ANRV386-GG10-23ARI29July200915:38
SIDEBAR4.CHANGINGTHENATURAL
HISTORYOFMAPLESYRUPURINEDISEASE

(MSUD)Between1966and1988,36Mennonitechildrenwerebornwith
MSUDinLancasterCounty.Theyallbecameencephalopathic

withintheﬁrstweekoflifeandrequiredweeksormonthsof

intensivehospitaltreatmentthatcosttensofthousandsofdollars.

Follow-upcarewasexpensive,faraway,anddisorganized(59,

73).MSUDpatientswereoftensickathomefordaysbefore

arrivingcomatoseinPhiladelphiawithcriticalcerebraledema.

Noaspectoftherapydealtspeciﬁcallywiththiscomplication,

and14(36%)ofthesechildrendiedofbrainherniationwithin

24hofhospitalization(59,73).
Since1989,wehavemanaged59Mennoniteinfantswith
MSUD.Thirty-two(59%)werediagnosedbetween12and

24hoflifebyon-siteaminoacidanalysisor,morerecently,di-

rectmutationdetectionfromumbilicalcordbloodusingreal-

timePCR.Amonginfantsdiagnosedbefore3daysofage,

94%weretreatedsafelyathome.Tomanagecriseslocally,we

madeMSUDhyperalimentationsolutionavailable2
4hadayat
LancasterGeneralHospitalandhadon-siteaminoacidanalysis

witha30-minturnaroundtime.Wehavesuccessfullymanaged

over200metaboliccrisesatLancasterGeneralwithanaverage

hospitalstayofjust4days.Bycombininggeneralpediatriccare

andspecializedservices,amuchlargernumberofmetaboliccrises

wereavertedoutofhospital;theoverallhospitalizationratefor

ourMSUDcohortiscurrentlyonly0.4hospitaldaysperpatient

peryear.
studiesofvitaminB
12deﬁciencyledtoreli-
ableandinexpensiveformsofreplacementther-

apy(61).Now,forMennonitechildrenwith

hereditaryB
12malabsorption(
AMNdeletion),oncedailysublingualmethyl-B
12preventslife-
threateninganemiaandspinalcordinjuryfor

about$30peryear.However,ifsublingual

methyl-B12weretobedevelopedasanewthera-
peutictoday,itwouldcostbetween$500million

and$2billiontobringtotheU.S.market,and

itscostwouldbeprohibitiveformanyself-pay

families(4).Althoughwecanexpectexciting

newadvancesinthetreatmentofgeneticdis-

ease,attendantcostswillputeffectivetherapies

beyondthereachofsomefamilies.
PLAINPEOPLEATTHE
FRONTIEROFGENOMIC

MEDICINEWhenMcKusickandcolleaguesbegantheir
studiesoftheAmishin1962(31),medicalge-

neticswasjustaﬂedgingdisciplineandmolec-

ularstudieswerelimitedtodescriptionsofab-

normalchromosomenumberandstructure(9).

Polymerasechainreactionwasnotintroduced

until1986(12),andpolymorphicmicrosatel-

litemarkerswerenotwidelyuseduntilthe

early1990s(50).TheHumanGenomeProject

startedinOctober1990,andthecompletedraft

ofthehumangenomewaspublishedinFebru-

ary2001(25,96).Thus,geneticdiscoveryinthe

Plaincommunitiesdevelopedinparallelwith

largereventstakingplaceintheﬁeldofge-

nomics.Geneticsciencehasbecomeacornerstone
ofmedicine,butthepracticeofmedicine

hasbeenequallyvitaltoprogressingenetic

science.Benchscientistsandclinicianshave

differentinterestsandresponsibilities.Basic

scientistsinvestigatephysiologicsystems,tis-

sues,membranes,pathways,andmolecules.

Theyareprimarilyconcernedwithpatternsand

mechanisms.Physicians,incontrast,areprin-

cipallyconcernedwiththewelfareofindivid-

uals,“forthepatientisnomerecollectionof

symptoms,signs,disorderedfunctions,dam-

agedorgans,anddisturbedemotions.[Thepa-

tient]ishuman,fearful,andhopeful,seeking

relief,help,andreassurance”(29).
Thesedifferingperspectivesinﬂuencehow
oneviewsprogressingenomicscience(82).

Considerthreedecadesofprogressincellu-

larimmunology.Overthepast30years,im-

munogeneticsresearchhasexpandedatanex-

plosivepace;wenowunderstandmanycellular

immuneresponsesinexquisitemolecularde-

tail(18).Yetamong41AmishandMennonite

childrenbornwithSCIDduringthesametime

period,onlyhalfreceivedabonemarrowtrans-

plantand63%diedby2yearsofage(88).There

waslittlefundingforpatient-centeredresearch

(34),andhospitalswithexpertiseinSCIDwere

farawayandcosttoomuch(57).
530Strauss
·Puffenberger
 ANRV386-GG10-23ARI29July200915:38
Wecamefacetofacewiththisproblemin
January2007,whenanAmishnewbornpre-

sentedtoourClinicwithOmennsyndrome,

avariantofSCID(
Figure8
)(88).Shewassick
anduninsured,andneededtimely,affordable

care.Wewereabletouse10KSNPgenotypes

fromthechildandhersiblingstodelineate

theRAG1/RAG2locus,andusedthesesame
datatoquicklyandinexpensivelyﬁndanHLA-

matchedstemcelldonoramonghersiblings.

Thisentireprocess—fromclinicalpresentation

togeneticdiagnosistodonoridentiﬁcation—

tooklessthantwoweeksandsavedthefam-

ilybetween$20,000and$80,000.Appliedge-

nomicsenabledaccesstolife-savingtherapy.
Inamedical-industrialresearchenviron-
mentthatviewscasereportsandsmallcohorts

aspoorevidence(98),thisoneAmishchild

gaveusaglimpseofMcKusick’svisionforge-

nomicmedicine(
Figure9
)whenhewrote:
“[G]enomicsislikelytorendermedicinemore

predictiveand,therefore,morepreventive
...onthetraditionalturfofclinicalmedicine,di-

agnosiswillbecomemorespeciﬁcandpre-

cise,andtreatmentalsomorespeciﬁcandsafer.

Genomics-basedindividualizationofmedical
careaimstoachievetherighttreatmentforthe

rightpatient”(50)(italicsadded).Thus,thefu-

tureoftranslationalgenomicsisabout
patientdiscovery
,notgenediscovery(14,34,77).The
ideahasamodernemphasisbutisnotnew;

Hippocratesbelievedthatdiseasesassuchdid

notexistinnature.Tohim,whatexistednatu-

rallyweresickpeople,andnotwopeoplewere

sickinexactlythesameway(77).
Theethicalimperativetocareforindivid-
ualswithgeneticdiseaseisapparent,butthe

scientiﬁcvalueofsuchworkshouldnotbeover-

looked.Theconnectionofagenetoahuman

phenotypeistheonlywaytofullyappreciatea

gene’sfunctioninvivo(24,49,55,59,83).In

thisrespect,mice,ﬁsh,andﬂieswillalwaysfall

shortofmodelinghumandisease(seesidebar

5,NewDiseasePathwaysinHumanBrain

Development).Theastutephysician,working

dailytocareforoneorafewpatientswitha

rareandcomplexdisorder,candevelopkey

insightsthatdeepenourunderstanding(68,90),
RAG1/RAG2
Chromosome 11
HLA gene cluster
Chromosome 6
246810121416182022
abcChromosome number
Figure8
AnAmishgirlwasbornin1993witherythroderma,hepatosplenomegaly,
hypereosinophilia,hypogammaglobulinemia,andBcelldeﬁciency.

Shegrewpoorlyandhadrecurrentinfections.Shewasprovisionallydiagnosed

withOmennsyndrome,avariantofseverecombinedimmunedeﬁciency

(SCID),butdiedat3monthsofagebeforethediagnosiscouldbeconﬁrmedor

atransplantattempted.InJanuary2007,hersisterpresentedasanewbornwith

alopeciaanderythroderma,developedasystemic
Staphylococcusaureus
infectionatthreeweeksofage,andhadimmunologicstudiesconsistentwithSCID.

(a)Ahomozygosityplotwasgeneratedfortheproband(
graypeaks
);identity-
by-state(IBS)plotsforeachpairwisecomparisonbetweentheprobandandher

unaffectedsiblingsweresuperimposedonthisplot.Genotype-identicalregions

(coloredlines
)betweentheprobandandhersiblings(i.e.,IBS
=2)denoteregions
wherethediseasegenecannotreside.Theredlineatthetopisasummaryofthe

exclusionmapping.Thisanalysisdemonstratedthatonlyasingle,homozygous

genomicregiononchromosome11wasconsistentwithlinkagewithin

thepedigree.(
b)The
RAG1andRAG2locimappedtothehomozygousinterval
onchromosome11.
RAG1sequencingrevealedhomozygosityforapathogenic
c.2974A>Gvariantinthepatient.(
c)Thehomozygosityplotofchromosome
6intheprobandandhersevenunaffectedsiblings.Comparedtotheproband,

onlyonesiblingishaplo-identicalforthemajorHLAlocionchromosome

6.Subsequently,HLAtypingofthepatientandherpotentialsiblingdonor

wasperformedusingstandardserotypingandmolecularprobes;thesedata

corroboratedtheSNPmatching.Thepatienthadasuccessfulunmodiﬁedbone

marrowtransplantat62daysofage.Sheisnow2yearsold,fullyengrafted,

andhealthy.DNAextractedfromparafﬁnizedbonemarrowshowedthather

sister,whodied14yearsearlier,wasalsohomozygousfor
RAG1c.2974A>G.www.annualreviews.org
•Genetics,Medicine,andthePlainPeople531
 ANRV386-GG10-23ARI29July200915:38
SIDEBAR5.NEWDISEASEPATHWAYSIN
HUMANBRAINDEVELOPMENT
In2006,wediscoveredahomozygousframeshiftmutationofthe
CNTNAP2geneinagroupofAmishchildrenwithcorticaldys-
plasia,focalepilepsy,anddevelopmentalregression(90).Remark-

ably,micewithhomozygous
Cntnap2mutationshavenocentral
nervoussystemdisease.Nevertheless,theﬁndingspromptednew

studiesabouttheroleof
CNTNAP2inhumanbraindevelopment.
Withintwoyearsthisgenewaslinkedtoidiopathicautism(5,10,

11),schizophrenia(32),andmutism(97)inoutbredpopulations

acrossthecountryandthroughouttheworld.Thus,thestudyof

rareMendeliandisorderslinksspeciﬁcgenefamiliesorprotein

networks—i.e.,“interactomes”—torelevantprocessesinhuman

biology.InthewordsofWilliamHarvey(ca.1657):“Natureis

nowhereaccustomedmoreopenlytodisplayhersecretmysteries

thanincaseswheresheshowstracesofherworkingsapartfrom

thebeatenpath;noristhereanybetterwaytoadvancetheproper

practiceofmedicinethantogiveourmindstothediscoveryof

theusuallawofnaturebycarefulinvestigationofcasesofrarer

formsofdisease.”
expandourdiagnosticcapabilities(88,89),and
createnewopportunitiesforprevention(34,

58,60,87).Intheeraofgenomicmedicine,

physiciansandmolecularbiologistswhowork

closelytogethercantranslatetheseinsightsinto

realclinicalbeneﬁts.Suchcollaborationswill

helpustacklebigproblemsatthefrontierof

genomicmedicine,includingmultigenicdis-

ease(e.g.,atherosclerosis,hypertension,men-

talillness,etc.),modiﬁergenes,andepigenetics

(24,30,64,78,79).
DISCLOSURESTATEMENT
Theauthorsarenotawareofanybiasesthatmightbeperceivedasaffectingtheobjectivityofthis

review.
ACKNOWLEDGMENTSWethankDonnaRobinsonandChristineHendricksonforassistanceindatacollectionandfor

theirexceptionalcontributionstopatientcare.Drs.NicholasRiderandTerrySharrerprovided

importantinsightsandhelpfulsuggestions.DonKraybillandhiscolleaguesattheYoungCenter

forAnabaptistStudies,ElizabethtownCollege,provideddemographicdata.HolmesandCaroline

MortonenvisionedtheClinicforSpecialChildrenandhadthetenacitytomakeitreal;weare
Figure9
VictorA.McKusick(
left),D.HolmesMorton
(right),andBowiesittingonthefrontporchatthe
ClinicforSpecialChildren,spring2007.
Finally,itisimportanttorememberthatad-
vancesinmolecularscienceonlyrevealwhat

canbedonewithgeneticinformation.Perhaps

thePlainpeoplecanteachussomethingimpor-

tantaboutwhatshouldbedonewithit(24,57).

TheOldOrdercommunitiesmeasurethevalue

ofmedicalresearchnotingrantawards,publi-

cations,oracademicpromotions,butinhuman

terms:alleviationofpain,preventionofdisabil-

ity,equitabledelivery,andfaircost.Theyun-

derstandthattotranslategeneticinformation

intobetterpublichealth,onemustﬁrstcom-

mittocaringforindividuals.
532Strauss
·Puffenberger
 ANRV386-GG10-23ARI29July200915:38
deeplyindebtedtothemfortheirextraordinaryexampleandongoingcontributionsto
peopleofthePlaincommunities.Finally,wethankthechildrenandfamilieswhomweserve;they

continuetoteachusmuchaboutscience,medicine,andmeaningfulwork(57).
LITERATURECITED
1.McKusickVA,ed.1978.
MedicalGeneticStudiesoftheAmish
.Baltimore:JohnsHopkinsUniv.Press
2.MartinJ,MartinVM,eds.1995.
WhatIsWrongwithOurBaby?
Ephrata,PA:GracePress.160pp.
3.HoneycuttA,DunlapL,ChenH,alHomsiG,GrosseS,SchendelD.2004.Economiccostsassociated
withmentalretardation,cerebralpalsy,hearingloss,andvisionimpairment—UnitedStates,2003.
Morb.Mortal.Wkly.Rep.
(MMWR)53:57–59
4.AdamsCP,BrantnerVV.2006.Estimatingthecostofnewdrugdevelopment:Isitreally802million
dollars?HealthAff.
25:420–285.AlarconM,AbrahamsBS,StoneJL,DuvallJA,PerederiyJV,etal.2008.Linkage,association,andgene-
expressionanalysesidentifyCNTNAP2asanautism-susceptibilitygene.
Am.J.Hum.Genet.
82:150–596.AllamandV,BrouxO,BourgN,RichardI,TischﬁeldJA,etal.1995.Geneticheterogeneityofautoso-
malrecessivelimb-girdlemusculardystrophyinageneticisolate(Amish)andevidenceforanewlocus.

Hum.Mol.Genet.
4:459–637.AllenF.1989.Countrydoctor:howaphysiciansolvedriddleofrarediseaseinchildrenofAmish.In
Wall
StreetJ.
Sept.20,1989
8.AllenF.1990.AmishandMennonitefamiliesspendaSaturdayraisingaclinic.In
WallStreetJ.
Nov.19,
19909.AllenG,BendaCE,BookJA,CarterCO,FordCE,etal.1961.Mongolism.
Am.J.Hum.Genet.
13:42610.ArkingDE,CutlerDJ,BruneCW,TeslovichTM,WestK,etal.2008.Acommongeneticvariantinthe
neurexinsuperfamilymemberCNTNAP2increasesfamilialriskofautism.
Am.J.Hum.Genet.
82:160–6411.BakkalogluB,O’RoakBJ,LouviA,GuptaAR,AbelsonJF,etal.2008.Molecularcytogeneticanalysis
andresequencingofcontactinassociatedprotein-like2inautismspectrumdisorders.
Am.J.Hum.Genet.
82:165–7312.BartlettJM,StirlingD.2003.Ashorthistoryofthepolymerasechainreaction.
MethodsMol.Biol.
226:3–613.BaumgartnerD,Scholl-BurgiS,SassJO,SperlW,SchweigmannU,etal.2007.ProlongedQTcintervals
anddecreasedleftventricularcontractilityinpatientswithpropionicacidemia.
J.Pediatr.
150:192–97,7e1
14.BelkinL.2005.Thedawnofgenomicmedicine.In
NYTimesMagazine.
Nov.6,2005
15.BerryW.2005.Localknowledgeintheageofinformation.In
TheWayofIgnorance
,ed.WBerry,
pp.113–26.Berkeley,CA:Counterpoint
16.BiasWB,Light-OrrJK,KrevansJR,HumphreyRL,HamillPV,etal.1969.TheStoltzfusbloodgroup,
anewpolymorphisminman.
Am.J.Hum.Genet.
21:552–5817.BotsteinD,WhiteRL,SkolnickM,DavisRW.1980.Constructionofageneticlinkagemapinmanusing
restrictionfragmentlengthpolymorphisms.
Am.J.Hum.Genet.
32:314–3118.BuckleyRH.2000.Advancesintheunderstandingandtreatmentofhumanseverecombinedimmuno-
deﬁciency.Immunol.Res.
22:237–5119.BullLN,CarltonVE,StrickerNL,BaharlooS,DeYoungJA,etal.1997.Geneticandmorphological
ﬁndingsinprogressivefamilialintrahepaticcholestasis(Bylerdisease[PFIC-1]andBylersyndrome):

evidenceforheterogeneity.
Hepatology26:155–6420.CarltonVE,HarrisBZ,PuffenbergerEG,BattaAK,KniselyAS,etal.2003.Complexinheritanceof
familialhypercholanemiawithassociatedmutationsinTJP2andBAAT.
Nat.Genet.
34:91–9621.ChaceDH,KalasTA,NaylorEW.2002.Theapplicationoftandemmassspectrometrytoneonatal
screeningforinheriteddisordersofintermediarymetabolism.
Annu.Rev.GenomicsHum.Genet.
3:17–4522.ChuganiHT,PhelpsME,MazziottaJC.1987.Positronemissiontomographystudyofhumanbrain
functionaldevelopment.
Ann.Neurol.
22:487–9723.CollinsFS,GreenED,GuttmacherAE,GuyerMS.2003.Avisionforthefutureofgenomicsresearch.
Nature
422:835–47www.annualreviews.org
•Genetics,Medicine,andthePlainPeople533
 ANRV386-GG10-23ARI29July200915:38
24.CollinsFS,McKusickVA.2001.ImplicationsoftheHumanGenomeProjectformedicalscience.
JAMA285:540–4425.ConsortiumIHGS.2001.Initialsequencingandanalysisofthehumangenome.
Nature
409:860–92126.CrossHE,KennelEE,LilienfeldAM.1968.CancerofthecervixinanAmishpopulation.
Cancer21:102–827.DavisRW.1995.
Emigrants,Refugees,andPrisoners:I.AnAidtoMennoniteFamilyResearch
.Provo,UT:
RichardWarrenDavis.427pp.
28.DobrowolskiSF,AngelettiJ,BanasRA,NaylorEW.2003.RealtimePCRassaystodetectcommonmu-
tationsinthebiotinidasegeneandapplicationofmutationalanalysistonewbornscreeningforbiotinidase

deﬁciency.
Mol.Genet.Metab.
78:100–729.EditorsT.2005.Thepracticeofmedicine.In
Harrison’sPrinciplesofInternalMedicine
,ed.DLKasper,
ASFauci,DLLongo,EBraunwald,SLHauser,JLJameson,pp.1–6.NewYork:McGraw-Hill
30.EgelandJA.1988.Ageneticstudyofmanic-depressivedisorderamongtheOldOrderAmishof
Pennsylvania.Pharmacopsychiatry
21:74–7531.FrancomanoCA,McKusickVA,BieseckerLG.2003.MedicalgeneticstudiesintheAmish:historical
perspective.Am.J.Med.Genet.CSemin.Med.Genet.
121C:1–432.FriedmanJI,VrijenhoekT,MarkxS,JanssenIM,VanDerVlietWA,etal.2008.CNTNAP2genedosage
variationisassociatedwithschizophreniaandepilepsy.
Mol.Psychiatry
13:261–6633.GeorgieffMK.2007.Nutritionandthedevelopingbrain:nutrientprioritiesandmeasurement.
Am.J.
Clin.Nutr.
85:614S–20S34.GoldsteinJL,BrownMS.1997.Theclinicalinvestigator:bewitched,bothered,andbewildered—butstill
beloved.J.Clin.Investig.
99:2803–1235.GolombHM,BahrGF,BorgaonkarDS.1971.Analysisofhumanchromosomalvariantsbyquantitative
electronmicroscopy.II.Ringchromosome18.
Chromosoma34:94–9836.GuthrieR,SusiA.1963.Asimplephenylalaninemethodfordetectingphenylketonuriainlargepopulations
ofnewborninfants.
Pediatrics32:338–4337.GuttmacherAE,JenkinsJ,UhlmannWR.2001.Genomicmedicine:Whowillpracticeit?Acalltoopen
arms.Am.J.Med.Genet.
106:216–2238.HallJE.2001.Thepromiseoftranslationalphysiology.
Am.J.Physiol.CellPhysiol.
281:C1411–1239.HayesA,CostaT,ScriverCR,ChildsB.1985.TheeffectofMendeliandiseaseonhumanhealth.II:
Responsetotreatment.
Am.J.Med.Genet.
21:243–5540.HollidayMA.1971.Metabolicrateandorgansizeduringgrowthfrominfancytomaturityandduring
lategastationandearlyinfancy.
Pediatrics47(Suppl.2):169
41.HostetlerJA.1963.
AmishSociety
.Baltmore:JohnsHopkinsUniv.Press.347pp.
42.HsuSH,PollardMK,ChanMM,BiasWB.1981.GeneticheterogeneityofDR4intheOldOrderAmish
andtwonewHLA-Dspeciﬁcities.
Hum.Immunol.
2:165–7243.JohnstonJJ,KelleyRI,CrawfordTO,MortonDH,AgarwalaR,etal.2000.Anovelnemalinemyopathy
intheAmishcausedbyamutationintroponinT1.
Am.J.Hum.Genet.
67:814–2144.JorgensonRJ,BollingDR,YoderOC,MurphyEA.1972.BloodpressurestudiesintheAmish.
JohnsHopkinsMed.J.
131:329–5045.KhouryMJ,GwinnM.2006.Whatroleforpublichealthingeneticsandviceversa?
CommunityGenet.
9:282;authorreply3
46.KnottnerusJA.2003.Communitygeneticsandcommunitymedicine.
Fam.Pract.
20:601–647.LimLE,DuclosF,BrouxO,BourgN,SunadaY,etal.1995.Beta-sarcoglycan:characterizationandrole
inlimb-girdlemusculardystrophylinkedto4q12.
Nat.Genet.
11:257–6548.MaxamAM,GilbertW.1977.AnewmethodforsequencingDNA.
Proc.Natl.Acad.Sci.USA
74:560–6449.McKusickVA.1973.GeneticstudiesinAmericaninbredpopulationswithparticularreferencetotheOld
OrderAmish.
Isr.J.Med.Sci.
9:1276–8450.McKusickVA.2001.Theanatomyofthehumangenome:aneo-Vesalianbasisformedicineinthe21st
century.JAMA286:2289–9551.McKusickVA.2006.A60-yeartaleofspots,maps,andgenes.
Annu.Rev.GenomicsHum.Genet.
7:1–2752.McKusickVA,EgelandJA,EldridgeR,KrusenDE.1964.DwarﬁsmintheAmish.I.TheEllis-Van
Creveldsyndrome.
Bull.JohnsHopkinsHosp.
115:306–36534Strauss
·Puffenberger
 ANRV386-GG10-23ARI29July200915:38
53.McKusickVA,EldridgeR,HostetlerJA,RuangwitU,EgelandJA.1965.DwarﬁsmintheAmish.II.
Cartilage-hairhypoplasia.
Bull.JohnsHopkinsHosp.
116:285–32654.McKusickVA,HostetlerJA,EgelandJA.1964.GeneticstudiesoftheAmish,backgroundandpotential-
ities.Bull.JohnsHopkinsHosp.
115:203–2255.McKusickVA,HostetlerJA,EgelandJA,EldridgeR.1964.ThedistributionofcertaingenesintheOld
OrderAmish.
ColdSpringHarb.Symp.Quant.Biol.
29:99–11456.MeyersDA,BiasWB,MarshDG.1982.AgeneticstudyoftotalIgElevelsintheAmish.
Hum.Hered
.32:15–2357.MortonDH.1994.Throughmywindow—remarksatthe125thyearcelebrationofChildren’sHospital
ofBoston.
Pediatrics94:785–9158.MortonDH,BennettMJ,SeargeantLE,NichterCA,KelleyRI.1991.GlutaricaciduriatypeI:acommon
causeofepisodicencephalopathyandspasticparalysisintheAmishofLancasterCounty,Pennsylvania.

Am.J.Med.Genet.
41:89–9559.MortonDH,MortonCS,StraussKA,RobinsonDL,PuffenbergerEG,etal.2003.Pediatricmedicine
andthegeneticdisordersoftheAmishandMennonitepeopleofPennsylvania.
Am.J.Med.Genet.C
Semin.Med.Genet.
121:5–1760.MortonDH,StraussKA,RobinsonDL,PuffenbergerEG,KelleyRI.2002.Diagnosisandtreatmentof
maplesyrupdisease:astudyof36patients.
Pediatrics109:999–100861.OkudaK.1999.DiscoveryofvitaminB
12intheliveranditsabsorptionfactorinthestomach:ahistorical
review.J.Gastroenterol.Hepatol.
14:301–862.PannainS,WeissRE,JacksonCE,DianD,BeckJC,etal.1999.Twodifferentmutationsinthethyroid
peroxidasegeneofalargeinbredAmishkindred:powerandlimitsofhomozygositymapping.
J.Clin.
Endocrinol.Metab.
84:1061–7163.PatelH,CrossH,ProukakisC,HershbergerR,BorkP,etal.2002.SPG20ismutatedinTroyersyndrome,
anhereditaryspasticparaplegia.
Nat.Genet.
31:347–4864.PollinTI,HsuehWC,SteinleNI,SnitkerS,ShuldinerAR,MitchellBD.2004.Agenome-widescanof
serumlipidlevelsintheOldOrderAmish.
Atherosclerosis173:89–9665.PuffenbergerEG.2003.GeneticheritageoftheOldOrderMennonitesofSoutheasternPennsylvania.
Am.J.Med.Genet.PartC
121C:18–3166.PuffenbergerEG,HosodaK,WashingtonSS,NakaoK,deWitD,etal.1994.Amissensemutationof
theendothelin-BreceptorgeneinmultigenicHirschsprung’sdisease.
Cell79:1257–6667.PuffenbergerEG,Hu-LinceD,ParodJM,CraigDW,DobrinSE,etal.2004.Mappingofsuddeninfant
deathwithdysgenesisofthetestessyndrome(SIDDT)byaSNPgenomescanandidentiﬁcationof

TSPYLlossoffunction.
Proc.Natl.Acad.Sci.USA
101:11689–9468.PuffenbergerEG,StraussKA,RamseyKE,CraigDW,StephanDA,etal.2007.Polyhydramnios,
megalencephalyandsymptomaticepilepsycausedbyahomozygous7-kilobasedeletioninLYK5.
Brain130:1929–4169.RedekopC.1989.
MennoniteSociety
.Baltimore:JohnsHopkinsUniv.Press.397pp.
70.ReesJ.2002.Complexdiseaseandthenewclinicalsciences.
Science296:698–70171.RidanpaaM,JainP,McKusickVA,FrancomanoCA,KaitilaI.2003.ThemajormutationintheRMRP
genecausingCHHamongtheAmishisthesameasthatfoundinmostFinnishcases.
Am.J.Med.Genet.
CSemin.Med.Genet.
121C:81–8372.RimoinDL.1969.Ethnicvariabilityinglucosetoleranceandinsulinsecretion.
Arch.Intern.Med.
124:695–70073.RomeroFJ,IbarraB,RoviraM,NatalA,HerreraM,SegarraA.1984.Cerebralcomputedtomography
inmaplesyrupurinedisease.
J.Comput.Assist.Tomogr.
8:410–1174.RosenbergMJ,AgarwalaR,BouffardG,DavisJ,FiermonteG,etal.2002.Mutantdeoxynucleotidecarrier
isassociatedwithcongenitalmicrocephaly.
Nat.Genet.
32:175–7975.Ruiz-PerezVL,IdeSE,StromTM,LorenzB,WilsonD,etal.2000.MutationsinanewgeneinEllis-van
CreveldsyndromeandWeyersacrodentaldysostosis.
Nat.Genet.
24:283–8676.SangerF,NicklenS,CoulsonAR.1977.DNAsequencingwithchain-terminatinginhibitors.
Proc.Natl.
Acad.Sci.USA
74:5463–67www.annualreviews.org
•Genetics,Medicine,andthePlainPeople535
 ANRV386-GG10-23ARI29July200915:38
77.SharrerT.2008.
PersonalizedMedicine:Ethics
,ed.KAStrauss.Strasburg
78.ShawJA,EgelandJA,EndicottJ,AllenCR,HostetterAM.2005.A10-yearprospectivestudyofprodromal
patternsforbipolardisorderamongAmishyouth.
J.Am.Acad.ChildAdolesc.Psychiatry
44:1104–1179.SnitkerS,ShuldinerAR.2004.BMIintheOldOrderAmish.
Med.Sci.SportsExerc.
36:1447;authorreply
880.SouthernEM.1975.DetectionofspeciﬁcsequencesamongDNAfragmentsseparatedbygelelec-
trophoresis.J.Mol.Biol.
98:503–1781.StoneDL,SlavotinekA,BouffardGG,Banerjee-BasuS,BaxevanisAD,etal.2000.Mutationofagene
encodingaputativechaperonincausesMcKusick-Kaufmansyndrome.
Nat.Genet.
25:79–8282.StraussKA.2005.Glutaricaciduriatype1:aclinician’sviewofprogress.
Brain128:697–9983.StraussKA,LazovicJ,WintermarkM,MortonDH.2007.Multimodalimagingofstriataldegeneration
inAmishpatientswithglutaryl-CoAdehydrogenasedeﬁciency.
Brain130:1905–2084.Deletedinproof

85.StraussKA,MazariegosGV,SindhiR,SquiresR,FinegoldDN,etal.2006.Electivelivertransplantation
forthetreatmentofclassicalmaplesyrupurinedisease.
Am.J.Transplant
6:557–6486.StraussKA,MortonDH.2003.Branched-chainketoacyldehydrogenasedeﬁciency:maplesyrupdisease.
Curr.Treat.OptionsNeurol.
5:329–4187.StraussKA,MortonDH,PuffenbergerEG,HendricksonC,RobinsonDL,etal.2007.Preventionofbrain
diseasefromsevere5,10-methylenetetrahydrofolatereductasedeﬁciency.
Mol.Genet.Metab.
91:165–7588.StraussKA,PuffenbergerEG,BuninN,RiderNL,MortonMC,etal.2008.ClinicalapplicationofDNA
microarrays:moleculardiagnosisandHLAmatchingofanAmishchildwithseverecombinedimmune

deﬁciency.Clin.Immunol.
128:31–3889.StraussKA,PuffenbergerEG,CraigDW,PanganibanCB,LeeAM,etal.2005.Genome-wideSNP
arraysasadiagnostictool:clinicaldescription,geneticmapping,andmolecularcharacterizationofSalla

diseaseinanOldOrderMennonitepopulation.
Am.J.Med.Genet.A
138:262–6790.StraussKA,PuffenbergerEG,HuentelmanMJ,GottliebS,DobrinSE,etal.2006.Recessivesymptomatic
focalepilepsyandmutantcontactin-associatedprotein-like2.
N.Engl.J.Med.
354:1370–7791.StraussKA,RobinsonDL,VremanHJ,PuffenbergerEG,HartG,MortonDH.2006.Managementof
hyperbilirubinemiaandpreventionofkernicterusin20patientswithCrigler-Najjardisease.
Eur.J.Pediatr.
165:306–1992.SulisaloT,FrancomanoCA,SistonenP,MaherJF,McKusickVA,etal.1994.High-resolutiongenetic
mappingofthecartilage-hairhypoplasia(CHH)geneinAmishandFinnishfamilies.
Genomics20:347–5393.TreacyE,ChildsB,ScriverCR.1995.Responsetotreatmentinhereditarymetabolicdisease:1993survey
and10-yearcomparison.
Am.J.Hum.Genet.
56:359–6794.ValasekMA,RepaJJ.2005.Thepowerofreal-timePCR.
Adv.Physiol.Educ.
29:151–5995.VelinovM,SarfaraziM,YoungK,HodesME,ConneallyPM,etal.1993.Limb-girdlemusculardystrophy
iscloselylinkedtotheﬁbrillinlocusonchromosome15.
Connect.TissueRes.
29:13–2196.VenterJC,AdamsMD,MyersEW,LiPW,MuralRJ,etal.2001.Thesequenceofthehumangenome.
Science291:1304–5197.VernesSC,NewburyDF,AbrahamsBS,WinchesterL,NicodJ,etal.2008.Afunctionalgeneticlink
betweendistinctdevelopmentallanguagedisorders.
N.Engl.J.Med.
359:2337–4598.ZiliakST,McCloskeyDN.2008.
TheCultofStatisticalSigniﬁcance
.AnnArbor:Univ.Mich.Press
536Strauss
·Puffenberger
 AR386-GG10-FMARI6August20097:15
AnnualReviewof
Genomicsand

HumanGenetics
Volume10,2009
ContentsChromosomesinLeukemiaandBeyond:FromIrrelevant
toCentralPlayers
JanetD.Rowley
1UnravelingaMultifactorialLate-OnsetDisease:FromGenetic
SusceptibilitytoDiseaseMechanismsforAge-RelatedMacular

DegenerationAnandSwaroop,EmilyY.Chew,CatherineBowesRickman,andGon¸
caloR.Abecasis
19SyndromesofTelomereShortening
MaryArmanios
45ChronicPancreatitis:GeneticsandPathogenesis
Jian-MinChenandClaudeF´
erec
63TheGeneticsofCrohn’sDisease
JohanVanLimbergen,DavidC.Wilson,andJackSatsangi
89GenotypingTechnologiesforGeneticResearch
JiannisRagoussis
117ApplicationsofNewSequencingTechnologiesforTranscriptome
AnalysisOlenaMorozova,MartinHirst,andMarcoA.Marra
135ThePosttranslationalProcessingofPrelaminAandDisease
BrandonS.J.Davies,LorenG.Fong,ShaoH.Yang,CatherineCofﬁnier,
andStephenG.Young
153GeneticTestinginIsrael:AnOverview
GuyRosner,SerenaRosner,andAviOrr-Urtreger
175StewardshipofHumanBiospecimens,DNA,Genotype,andClinical
DataintheGWASEra
StephenJ.O’Brien
193SchistosomaGenetics:NewPerspectivesonSchistosomeBiology
andHost-ParasiteInteraction
Ze-GuangHan,PaulJ.Brindley,Sheng-YueWang,andZhuChen
211EvolutionofGenomicImprinting:InsightsfromMarsupials
andMonotremes
MarilynB.Renfree,TimothyA.Hore,GeoffreyShaw,
JenniferA.MarshallGraves,andAndrewJ.Pask
241v AR386-GG10-FMARI6August20097:15
MethodsforGenomicPartitioning
EmilyH.Turner,SarahB.Ng,DeborahA.Nickerson,andJayShendure
263BiasedGeneConversionandtheEvolutionofMammalian
GenomicLandscapes
LaurentDuretandNicolasGaltier
285InheritedVariationinGeneExpression
DanielA.Skelly,JamesRonald,andJoshuaM.Akey
313GenomicAnalysesofSexChromosomeEvolution
MelissaA.WilsonandKaterynaD.Makova
333SequencingPrimateGenomes:WhatHaveWeLearned?
TomasMarques-Bonet,OliverA.Ryder,andEvanE.Eichler
355GenotypeImputation
YunLi,CristenWiller,SerenaSanna,andGon¸
caloAbecasis
387GeneticsofAthleticPerformance
ElaineA.Ostrander,HeatherJ.Huson,andGaryK.Ostrander
407GeneticScreeningforLow-PenetranceVariants
inProtein-CodingDiseases
JillWaalenandErnestBeutler
431CopyNumberVariationinHumanHealth,Disease,andEvolution
FengZhang,WenliGu,MatthewE.Hurles,andJamesR.Lupski
451TheToxicogenomicMultiverse:ConvergentRecruitmentofProteins
IntoAnimalVenoms
BryanG.Fry,KimRoelants,DonaldE.Champagne,HolgerScheib,
JoelD.A.Tyndall,GlennF.King,TimoJ.Nevalainen,JanetteA.Norman,

RichardJ.Lewis,RaymondS.Norton,CamilaRenjifo,

andRicardoC.RodríguezdelaVega
483Genetics,Medicine,andthePlainPeople
KevinA.StraussandErikG.Puffenberger
513IndexesCumulativeIndexofContributingAuthors,Volumes1–10
537CumulativeIndexofChapterTitles,Volumes1–10
541ErrataAnonlinelogofcorrectionsto
AnnualReviewofGenomicsandHumanGenetics
articlesmaybefoundathttp://genom.annualreviews.org/
viContents
